Cocoa Flavanols — Endothelial Support and Cognitive Health

Cocoa flavanols, particularly (-)-epicatechin, primarily act by enhancing endothelial nitric oxide (NO) production. They activate endothelial nitric oxide synthase (eNOS), leading to vasodilation, improved blood flow, and reduced arterial stiffness. Downstream, this improved vascular function supports cardiovascular and cerebrovascular health. Flavanols also exhibit antioxidant and anti-inflammatory properties, potentially modulating NF-κB signalling and reducing oxidative stress in vascular tissues.

The COSMOS trial (2022) is the largest study to date, randomising over 21,000 older adults to 500 mg/day of cocoa flavanols. While it did not significantly reduce total cardiovascular events, it showed a significant 27% reduction in cardiovascular death. The COSMOS-Mind sub-study found no significant effect of cocoa extract on global cognitive function, though other smaller trials have shown improvements in endothelial function, blood pressure, and insulin sensitivity.

500 mg/day of cocoa flavanols (often standardised to contain ~80 mg (-)-epicatechin) is the most studied dose in large clinical trials like COSMOS. Typically taken once daily with or without food. Powders, capsules, or high-flavanol dark chocolate are common delivery methods, though commercial chocolate varies widely in flavanol content due to processing.

Generally well tolerated at standard doses. Mild gastrointestinal upset or nausea can occur. Cocoa extracts may contain trace amounts of caffeine and theobromine, which could cause jitteriness or sleep disturbances in highly sensitive individuals. Caution is advised for those with bleeding disorders or taking anticoagulant medications, as flavanols may have mild antiplatelet effects.

Key Papers